Molecule intelOpportunity: StrongEssential

Medroxyprogesterone

21 brands · 14 companies · product forms

ATC: G03AC06, G03DA02, L02AB02 5 DRAP alerts

Opportunity snapshot

Launch attractiveness
62
Market saturation
37
Price room
100
Regulatory risk
90
21
brands
14
companies
Rs 6,104.83
median price
13
price points
852.9x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 24%

Price room

Across observed sources and strengths
CheapestRs 149.86
MedianRs 6,104.83
Most expensiveRs 127,815.44
Spread852.9×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 852.90x across 13 trusted points (Rs 149.86-127815.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 4 live products for Medroxyprogesterone — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2025-09-10
RECALL ALERT – DRUG PRODUCTS DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORATORY, KARACHI.
Risk of Meningioma with Medroxyprogesterone Acetate.
Recall Alert: Drug Product; Famila 150mg Injection (Batch # 083) By Zafa Pharmaceutical La
RECALL ALERT – BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORA
RECALL ALERT – FAMILA 28F TABLETS (Batch # K159, K196, K197, K198) DECLARED SUBSTANDARD.

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(63) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

14 canonical companies and 21 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 852.90x across 13 trusted points (Rs 149.86-127815.44). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

5 DRAP alert(s), latest 2025-09-10 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.